Clinical Trial Update: A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study evaluated almotriptan malate for treating migraines in adolescents; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Axert (Almotriptan)

Snippet

Sponsor: Janssen-Ortho LLC | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2013-12-06